# A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

> **NCT06791005** · PHASE3 · RECRUITING · sponsor: **Second Affiliated Hospital of Xi'an Jiaotong University** · enrollment: 400 (estimated)

## Conditions studied

- Papillary Thyroid Cancer

## Interventions

- **DRUG:** Preoperative Injection of Carbon Nanoparticles
- **DRUG:** Intraoperative Injection of Carbon Nanoparticles

## Key facts

- **NCT ID:** NCT06791005
- **Lead sponsor:** Second Affiliated Hospital of Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06791005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06791005, "A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06791005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*